{"summary": "ARMS-I is patented novel formulation for the prevention and treatment of URIs. it includes a broad-spectrum antimicrobial agent (cetylpyridinium chloride, CPC) and components (glycerin and xanthan gum) that form a barrier on the host mucosa, thus preventing viral contact and invasion. ARMS-I tended to provide protection against URIs in the enrolled study participants, while reducing severity and duration of cough and sore throat. electronic supplementary material The online version of this article contains supplementary material."}